Huang F, Yan AT. Mapping the burden of atherosclerosis: global lessons from Portugal. Eur Heart J Qual Care Clin Outcomes. 2021;7(2):117–8. https://doi.org/10.1093/ehjqcco/qcaa086.
Ishikawa H, Otsuka K, Kono Y, et al. Extent of coronary atherosclerosis is associated with deterioration of left ventricular global longitudinal strain in patients with preserved ejection fraction undergoing coronary computed tomography angiography. Int J Cardiol Heart Vasc. 2023;44:101176. https://doi.org/10.1016/j.ijcha.2023.101176.
Article PubMed PubMed Central Google Scholar
Jia L, Cheng A, Alam N, et al. Global Trends in Atherosclerosis Research in the epigenetics Field: bibliometric and visualization studies. Int J Environ Res Public Health. 2021;18(24). https://doi.org/10.3390/ijerph182413154.
Tian W, Zhang T, Wang X, et al. Global research trends in atherosclerosis: a bibliometric and visualized study. Front Cardiovasc Med. 2022;9:956482. https://doi.org/10.3389/fcvm.2022.956482.
Article CAS PubMed PubMed Central Google Scholar
Chiu MH, Kaitoukov Y, Roze des Ordons A. Late stent thrombosis in a patient with endovascular aortic repair for Blunt thoracic aortic Injury. Case Rep Vasc Med. 2022;2022:5583120. https://doi.org/10.1155/2022/5583120.
Article PubMed PubMed Central Google Scholar
Kumar T, Shah MM, Prajapati A, Pathak S. A case of very very late stent thrombosis: more than 12 years after DES. J Family Med Prim Care. 2022;11(4):1545–8. https://doi.org/10.4103/jfmpc.jfmpc_1533_21.
Article PubMed PubMed Central Google Scholar
Okada S, Yamada Y, Ezure M, et al. [Very late stent thrombosis during Perioperative Period of aortic valve replacement:report of a case]. Kyobu Geka. 2023;76(3):216–20.
Toyoshima T, Iida O, Mano T. Very late stent thrombosis caused by the rupture of in-stent neoatherosclerosis 15 years after bare nitinol stent implantation in superficial femoral artery visualized with multimodality imaging. Eur Heart J Case Rep. 2022;6(7):ytac264. https://doi.org/10.1093/ehjcr/ytac264.
Article PubMed PubMed Central Google Scholar
Kawamura Y, Tamura N, Goto S, Goto S. Computer Simulation of platelet adhesion around stent struts in the Presence and absence of tissue defects around them. J Interv Cardiol. 2021;2021:8880988. https://doi.org/10.1155/2021/8880988.
Article PubMed PubMed Central Google Scholar
Lenz-Habijan T, Bhogal P, Peters M, et al. Hydrophilic stent Coating inhibits platelet adhesion on Stent surfaces: initial results in Vitro. Cardiovasc Intervent Radiol. 2018;41(11):1779–85. https://doi.org/10.1007/s00270-018-2036-7.
Article PubMed PubMed Central Google Scholar
Pan CJ, Shao ZY, Tang JJ, Wang J, Huang N. In vitro studies of platelet adhesion, activation, and protein adsorption on curcumin-eluting biodegradable stent materials. J Biomed Mater Res A. 2007;82(3):740–6. https://doi.org/10.1002/jbm.a.31108.
Article CAS PubMed Google Scholar
Tang H, Wang Q, Wang X, et al. Effect of a Novel Stent on Re-endothelialization, platelet adhesion, and neointimal formation. J Atheroscler Thromb. 2016;23(1):67–80. https://doi.org/10.5551/jat.31062.
Article CAS PubMed Google Scholar
Cancel M, Fromont G, Blonz C, et al. Everolimus or sunitinib as first-line treatment of metastatic papillary renal cell carcinoma: a retrospective study of the GETUG group (Groupe d’Etude Des Tumeurs Uro-Genitales). Eur J Cancer. 2021;158:1–11. https://doi.org/10.1016/j.ejca.2021.08.046.
Article CAS PubMed Google Scholar
de la Torre Hernandez JM, Lee DH, Garcia Camarero T, et al. Two-month healing evaluation of an everolimus Pt-Cr DES with erodible polymer and two bioresorbable scaffolds implanted in the same vessel of the same patient. EuroIntervention. 2015;10(12):e1–2. https://doi.org/10.4244/EIJV10I12A252.
Kang DY, Lee CH, Lee PH, et al. Comparison of resolute zotarolimus-eluting and Xience everolimus-eluting stents in patients with de novo long coronary artery lesions: a randomized LONG-DES VI trial. Coron Artery Dis. 2019;30(1):59–66. https://doi.org/10.1097/MCA.0000000000000680.
Park DW, Kim YH, Song HG, et al. Comparison of everolimus- and sirolimus-eluting stents in patients with long coronary artery lesions: a randomized LONG-DES-III (Percutaneous treatment of LONG native coronary lesions with drug-eluting Stent-III) trial. JACC Cardiovasc Interv. 2011;4(10):1096–103. https://doi.org/10.1016/j.jcin.2011.05.024.
Sun LX, Zhang J. Biodegradable polymer DES versus durable polymer everolimus-eluting stents for patients undergoing PCI: a meta-analysis. Heart Lung Circ. 2014;23(6):496–502. https://doi.org/10.1016/j.hlc.2013.11.006.
Bae IH, Jeong MH, Lim KS, et al. Novel polymer-free Everolimus-Eluting Stent fabricated using Femtosecond Laser improves re-endothelialization and anti-inflammation. Sci Rep. 2018;8(1):7383. https://doi.org/10.1038/s41598-018-25629-9.
Article CAS PubMed PubMed Central Google Scholar
Baek SW, Kim DS, Song DH, et al. Reduced restenosis and enhanced re-endothelialization of functional biodegradable vascular scaffolds by everolimus and magnesium hydroxide. Biomater Res. 2022;26(1):86. https://doi.org/10.1186/s40824-022-00334-x.
Article CAS PubMed PubMed Central Google Scholar
Kook H, Kim HD, Shim J, et al. Comparison of clinical outcomes between multiple antithrombotic therapy versus left atrial appendage occlusion with dual antiplatelet therapy in patients with atrial fibrillation undergoing drug-eluting stent implantation. PLoS ONE. 2021;16(1):e0244723. https://doi.org/10.1371/journal.pone.0244723.
Article CAS PubMed PubMed Central Google Scholar
Kuno T, Ueyama H, Takagi H, Bangalore S. The risk of stent thrombosis of dual antithrombotic therapy for patients who require oral anticoagulant undergoing percutaneous coronary intervention: insights of a meta-analysis of randomized trials. Scand Cardiovasc J. 2022;56(1):1–3. https://doi.org/10.1080/14017431.2021.2025264.
Article CAS PubMed Google Scholar
Shoji K, Zen K, Ookura T, Yanishi K, Matoba S. Early stent thrombosis confirmed in a cancer patient receiving regorafenib, despite triple antithrombotic therapy: a case report. BMC Cardiovasc Disord. 2021;21(1):60. https://doi.org/10.1186/s12872-021-01888-9.
Article PubMed PubMed Central Google Scholar
Tran MA, Lakhanpal P, Lakhanpal S, et al. Type of anti-thrombotic therapy for venous stenting in patients with non-thrombotic iliac vein lesions does not influence the development of in-stent restenosis. Phlebology. 2020;35(10):805–13. https://doi.org/10.1177/0268355520941385.
Zagnoni S, Campo G, Sciahbasi A, Rubboli A. In-hospital antithrombotic therapy and outcomes of elderly patients on warfarin undergoing percutaneous coronary intervention: insights from the WAR-STENT registry. Indian Heart J. 2022;74(3):256–7. https://doi.org/10.1016/j.ihj.2022.04.011.
Article PubMed PubMed Central Google Scholar
Tang R, Zhang G, Chen SY. Smooth muscle cell proangiogenic phenotype Induced by Cyclopentenyl Cytosine promotes endothelial cell proliferation and Migration. J Biol Chem. 2016;291(52):26913–21. https://doi.org/10.1074/jbc.M116.741967.
Article CAS PubMed PubMed Central Google Scholar
Zhu Y, Farrehi PM, Fay WP. Plasminogen activator inhibitor type 1 enhances neointima formation after oxidative vascular injury in atherosclerosis-prone mice. Circulation. 2001;103(25):3105–10. https://doi.org/10.1161/01.cir.103.25.3105.
Article CAS PubMed Google Scholar
Badano LP, Oikonomou KA, Fioretti PM. Acute thrombosis of mechanical mitral valve prosthesis: echo-doppler diagnosis and successful treatment with systemic thrombolysis. Eur J Echocardiogr. 2003;4(1):73–5. https://doi.org/10.1053/euje.2002.0614.
Article CAS PubMed Google Scholar
Barrellier MT, Le Hello C, Verfaille M, et al. [Echo-doppler monitoring of asymptomatic distal deep vein thrombosis in patients given low-molecular-weight-heparin at prophylactic doses after orthopedic surgery]. J Mal Vasc. 2000;25(3):195–200.
Delcker A, Haussermann P, Weimar C. Effect of echo contrast media on the visualization of transverse sinus thrombosis with transcranial 3-D duplex sonography. Ultrasound Med Biol. 1999;25(7):1063–8. https://doi.org/10.1016/s0301-5629(99)00068-x.
留言 (0)